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ess: mariab@terra.comSummary A prospective cohort study of adult patients hospitalized due to
community-acquired pneumonia was carried out for 1 year in a Brazilian university
general hospital to detect the incidence of community-acquired pneumonia by
Legionella pneumophila serogroups 1–6. During a whole year, a total of 645
consecutive patients who were hospitalized due to a initial presumptive diagnosis of
respiratory disease by ICD-10 (J00–J99), excluding upper respiratory diseases, were
screened to detect the patients with community-acquired pneumonia. Fifty-nine
consecutive patients hospitalized due to community-acquired pneumonia between
July 19, 2000 and July 18, 2001, were included in the study. They had determinations
of serum antibodies to L. pneumophila serogroups 1–6 by indirect immunofluores-
cence antibody test at the Infectious Diseases Laboratory of University of Louisville
(KY, USA) and urinary antigen tests for L. pneumophila serogroup 1. Three patients
had community-acquired pneumonia by L. pneumophila serogroups 1–6, two
patients being diagnosed by seroconversion and positive urinary antigen tests; the
other had negative serologies but strongly positive urinary antigen test. The
incidence of community-acquired pneumonia by L. pneumophila serogroups 1–6 in
our hospital was 5.1%.
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Legionella infections are difficult to diagnose
because the bacteria is not seen at Gram stain;
culture may have a sensitivity of 26%,1 reaching 80%
at laboratories of excellence,2 while for the direct
fluorescent antibody test it may vary from 25% to
70%.3 PCR techniques are still not recommended for
clinical diagnosis.4 The most used test has been
serum antibody detection by immunofluorescence
or enzyme-linked immunosorbent assay (ELISA), by
demonstration of fourfold rise in the immunofluor-
escent antibody titer of greater than or equal to
1:128 against Legionella pneumophila serogroup 1
between paired acute- and convalescent-phase
serum specimens, whose sensitivity ranges be-
tween 70% and 80%,3 but can be as low as 36%.1
The sensitivity of the Legionella urinary antigen
test in a review ranged from 86% to 93%.4 It has
become a definitive criterion for the diagnosis of
Legionella pneumonias,5 being recommended to
the diagnosis of community-acquired pneumonia
that requires hospitalization.6,7
The incidence of Legionella species community-
acquired pneumonia in many countries has ranged
from 1% to 16%.8 Such incidence has not been
estimated in Brazil so far, also there is no report of
the use of the Legionella urinary antigen test for
the diagnosis of Legionella pneumonias. The aim of
this study is to detect the incidence of community-
acquired pneumonia by L. pneumophila serogroups
1–6 in hospitalized patients in a southern Brazilian
general university hospital, and to report their
clinical picture and evolution.Methods and materials
This prospective study was approved by the
institutional Committee of Ethics in Research. All
consenting individuals with ages between 18 and 80
admitted to our university general hospital due to
an initial presumptive diagnosis of respiratory
disease by ICD-10 (J00–J99), excluding upper
respiratory diseases, were screened to detect the
patients with community-acquired pneumonia.
They were enrolled in the study if their
chest radiograph taken within 48 h of admission
indicated pneumonia and had either one of the
major criteria (axillary temperature p35.5 1C or
X37.8 1C, cough or sputum) or two of the minor
criteria (dyspnea, abnormal mental status, signs of
consolidation by examination, pleuritic chest pain,
white blood count 412 000 cells per cm3 or band
forms 44%).Underlying chronic disease was defined as pre-
sence of heart disease, liver disease, renal disease,
lung disease or diabetes mellitus. Underlying
disease with immunosuppression was defined as
presence of HIV infection, splenectomy, hematolo-
gical malignancy, autoimmune disorder, transplant
recipients and receipt of cancer chemotherapy
within 4 weeks9 or prednisolone use of at least
10mg/day (or equivalent doses of other steroids) in
the last 3 months.10
Exclusion criteria were: residents in institutions,
those disabled to walk, hospitalization in the
preceding 15 days, pregnant women, HIV-positive
patients, cystic fibrosis, patients with bronchiecta-
sis or tracheostomy. Routine tests (chest radio-
graph, blood nitrogen, serum creatinine,
erythrocyte sedimentation rate, sputum Gram stain
and culture, blood cultures) were asked at the
discretion of the attending doctor. Urine and serum
samples were collected during the first week; and a
second serum sample after 4–12 weeks. Radiologi-
cal exams were all interpreted by an experienced
radiologist (Ilha, DO) according to the thoracic
radiology nomenclature.11,12 Sera stored at 70 1C
were further sent on dry ice in a batch to the
Infectious Diseases Laboratory of the University of
Louisville (KY, USA) to be tested for IgG, IgM, and
IgA serum antibodies to L. pneumophila serogroups
1–6 by indirect immunofluorescence antibody test
(Zeus Scientific Inc., Raritan, NJ, USA), starting at
1:8. All the urine samples were frozen to be tested
in batches at our laboratory using the kit Legionella
urinary enzyme assay (EIA BINAX, Portland, ME,
USA). A ratio X3 in comparison to duplicate test
samples with a negative control was considered
positive. Positive urine samples were refrozen and
further sent to the American laboratory to be
confirmed by the same kit test.
Diagnostic criteria of L. pneumophila serogroups
1–6 acute infection were either a fourfold rise in
antibody titer to at least 1:128 or positive urinary
antigen test. The cumulative incidence of commu-
nity-acquired pneumonia caused by L. pneumophila
serogroup 1–6 in our university hospital for a year
was calculated.Results
During a whole year, 645 consecutive patients who
were hospitalized due to an initial presumptive
diagnosis of respiratory disease by ICD-10
(J00–J99), excluding upper respiratory diseases,
were examined at hospital admission to exclude or
confirm CAP. Most were not included due to reasons
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eligible to be studied with the diagnosis of CAP,
from which group 23 patients were further ex-
cluded either because a new pulmonary infiltrate
was not confirmed with chest radiograph (five
patients) or alternative diagnoses were made
(COPD, five patients; heart failure, three; tubercu-
losis, two; collagen vascular diseases, one; idio-
pathic pulmonary fibrosis, one. The other six
patients had exclusion criteria by being HIV positive
(one), presenting bronchiectasis (four) or previous
pneumatocele (one). Thus, 59 patients constituted
the final study group, being 20 women and 39 men,
with a median age of 57.6 years (SD ¼ 10.5). From
this group, 36 (61%) pacients had underlying
chronic diseases; 61% were smokers and 19% were
imunosuppressed.
Only seven patients had some seropositivity to
L. pneumophila serogroups 1–6 (Table 2). Two
patients did not have convalescent samples due to
death. Only two had seroconversion, thus being
serologically proven cases of community-acquired
pneumonia by L. pneumophila serogroups 1–6.
The serum sample of acute phase and the urine
sample were collected in 54 out of 59 patients
during the first week of hospitalization (media: 4.2
days; SD: 2.4 days). In the remaining five patients,
they were collected after the 10th day.
The urinary antigen test was positive in only
three patients (Table 3).The urine of patient 1 was
collected on the first day of admission, while in
patients 2 and 3 on the third and fifth day of
admission, respectively. The first patient had his
urine tested at our laboratory after it was stored in
the freezer for 5 months; the second and third
patient had his urine stored, respectively, for 3 and
2 months before being tested. After that, they
were refrozen and kept in freezer for 4 more
months before being sent to the Infectious Diseases
Laboratory of University of Louisville (KY, USA),
where only the urine samples of patients 1 and 2
were confirmed positives (Table 3).
Out of the 59 community-acquired pneumonia
patients, 11 died, 7 being deaths due to pneumonia
(11.9%). All our three patients with L. pneumophila
serogroup 1–6 were cured.
Patient 1—A 63-year-old male, current heavy
smoker with systemic hypertension consulted in the
emergency room with axillary temperature of
39.5 1C, complaining of chills, cough and dyspnea
which started 3 days before. Chest radiograph
showed pneumonia in the inferior right lobe and in
part of right middle lobe (Fig. 1). He was prescribed
PO amoxicillin-clavulanate 1 gr q8 h in ambulatorial
regimen but after 2 days he entered the hospital
due to worsening of the symptoms, with diarrhea,yellow sputa and high-grade fever. Axillary tem-
perature was 39.3 1C; white blood count 13.3/ml,
segmented forms 78%, band forms 8%, lymphocytes
11%, monocytes 2%, metamyelocytes 1%; sodium
serum concentration 127mEq/l, SGOT 60U/l, SGPT
38U/l, alkaline phosphatase 374UI/l, total bilir-
ubin 1mg/dl, direct bilirubin 0.5mg/dl. Blood and
sputum cultures were negatives. Auscultation
revealed diminished breath sounds and rhonchi
diffusely, and crackles over the right posterior lung,
in the middle and inferior lung fields. He received
IV ampicillin-sulbactam plus IV clarithromycin for 6
days, which were replaced by IV levofloxacin for 10
days due to allergic cutaneous reaction. After 5
days of treatment, despite antibiotic treatment
and fever resolution, alkaline phosphatase had
risen to 885UI/l, SGOT to 188 UI/l and band forms
to 16%. After 21 days of treatment, despite clinical
and laboratorial improvement and a slight radi-
ological regression, the lesions of the superior
segment of the inferior right lung had progressed
(Fig. 2), and a slight new consolidation had
appeared in the superior right lobe which were
both confirmed by a thorax computed tomography
(CT), which also showed centrilobular emphysema
(Fig. 3). A second thorax CT, 1 year later, showed
complete resolution of the pneumonic lesions.
Patient 2—A 40-year-old female consulted in the
emergency room with vomiting, axillary tempera-
ture of 38 1C, complaining of pleuritic chest pain in
the left, dry cough, and worsening of dyspnea in
the last 3 days. The patient took PO azathioprine
7.5mg on an alternate-day regimen, chloroquine
250mg/day and prednisone 60mg/day for systemic
lupus erithematosus and CREST syndrome. She took
also PO captopril 100mg/day to systemic hyperten-
sion. She also had chronic renal failure and anemia.
She had been hospitalized 3 months back but no
lung problems other than chronic intersticial
pulmonary lesions due to collagen vascular disease
were found. Chest radiograph showed bilateral
bronchopneumonia (Fig. 4). She was prescribed
PO amoxicillin-clavulanate 1 gr q8 h, but after 3
days she agreed to be hospitalized owing to
persistent high fever. She had purulent, slightly
blood-tinged sputa, fever of 38.6 1C and oral
candidiasis. Auscultation revealed late inspiratory
crackles in both inferior lung fields, as she used
to present. Sputum and blood cultures were
negative. Hematocrit 30%, hemoglobin 10 g/dl,
white blood count 6100, band forms 10%, segmen-
ted forms 76%. Chest radiograph at admission
showed a progression of the pneumonic lesions
(Fig. 5). She was prescribed oral fluconazole plus IV
levofloxacin for 14 days and discharged. A blood
culture taken on the fourth day of hospitalization
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Table 1 Exclusion criteria in 563 patients presenting presumed respiratory disease at hospital admission by ICD-
10 (J00–J99), excluding upper respiratory diseases.
Exclusion criteria n %
(I) Patients immediately excluded
1. o18 years old 42 7.5
2. X80 years old 47 8.3
3. Hospital discharge in the preceding 15 days 27 4.8
4. Institutionalized patients, nursing home 2 0.3
5. HIV-positives at admission 18 3.2
6. Using tracheostomy 2 0.3
7. Cistic fibrosis 3 0.5
8. Hemiparesis 57 10.1
9. Paralysis of leg and foot 7 1.2
10. Bronquiectasis 7 1.2
11. Patients completely disabled to walk 14 2.5
Total 226 40.1
(II) Patients further examined who did not have any infiltrate in chest X-ray in the first 48 h
1. Hypertensive crisis 1 0.2
2. Cirrosis (acute) 1 0.2
3. Renal failure 3 0.5
4. Stroke (acute) 1 0.2
5. Meningitis 4 0.7
6. Cancer 9 1.6
7. Febrile neutropenia 2 0.3
8. Alcohol withdrawal syndrome 1 0.2
9. Ketoacidosis 2 0.3
10. Shock or septicemia (lung not the primary source) 6 1.1
11. Diagnosis not known yet 158 28.1
Total 188 33.4
(III) Presumed pneumonia patients whose clinical or radiological criteria of pneumonia were not confirmed in the
first week of hospitalization
1. Pneumotorax 4 0.7
2. COPD only 23 4.1
3. Asthma exacerbation 7 1.2
4. TB (active) 26 4.6
5. TB (not active) with hemoptysis and/ or respiratory bacterial infection 2 0.3
6. Pleural effusion only 9 1.6
7. Pulmonary fibrosis 7 1.2
8. Lung tumor only 12 2.1
9. Sinus infection and bronchitis (acute) 2 0.3
10. Silicosis 1 0.2
11. Mitral stenosis 2 0.3
12. Acute pulmonary edema 2 0.3
13. MI 1 0.2
14. Congestive heart failure 10 1.8
15. Mediastinal mass 1 0.2
Total 109 19.4
(IV) Patients not examined
1. Death in the first 24–48 h 12 2.1
2. Discharged in the first 24–48 h 16 2.9
3. Patients denying participation 3 0.5
4. Patients not available to be examined more than twice 9 1.6
Total 40 7.1
Total 563 100
Community-acquired pneumonia 969
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Table 3 Positive results of L. pneumophilla serogroup 1 test and serology results in three out of 59 patients
hospitalized due to community-acquired pneumonia.
Patient initials/serology result At Brazilian laboratory At American laboratory
Result Ratio Result Ratio
1. ACB/positive (seroconversion) Positive 6.0 Positive 30
2. SBG/positive (seroconversion) Positive 16.3 Positive 27
3. JPA/negative (not reagent at 1:8) Positive 13.5 Negative 1.2
All the remaining 56 patients had negative urinary antigen tests.
Table 2 Patients with community-acquired pneumonia who presented seropositivity to Legionella pneumophila
serogroup 1–6 by indirect immunofluorescence antibody test at the Infectious Diseases Laboratory of University of
Louisville (KY, USA).
Patients initials 1st sample
(acute phase)
2nd sample
(convalescent phase)
1. ACB o8 1024
2. SBG o8 128
3. CAC o8 32
4. MRS 16 —
5.WP 16 o8
6. CRCL 32 —
7. OJS 64 —
—Serum sample not obtained.o8 means Not Reagent at 1:8.
Figure 1 Chest radiograph of patient 1 showing large
alveolar consolidations in the inferior right lobe (IRL) and
in part of middle lobe.
Figure 2 Chest radiograph of patient 1 after a 21-day-
treatment with macrolides and levofloxacin showing that
despite a slight regression of the opacities of the IRL and
middle lobe, there was a progression of the lesions to the
superior segment of IRL and a new consolidation in the
superior right lobe.
M.B.F. Chedid et al.970yielded Staphylococcus sp. sensitive to penicillin,
ampicillin, oxacillin, clindamycin and erythromy-
cin. After 2 months a chest radiograph (Fig. 6)
showed a significant regression of the infectious
lung lesions. A concomitant high-resolution com-
puted tomography of the thorax (HRCT) showeddecreased pneumonic lesions and the intersticial
chronic pulmonary lesions of collagen vascular
disease.(Fig. 7). After 8 months, a new chest
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of the pneumonic lesions.
Patient 3—A 77-year-old male consulted in the
emergency room complaining of coughing in the
last 3 days and fever. He did not have history of
respiratory diseases in the preceding year. The
patient took PO levodopa and carbidopa for
Parkinson’s disease but no medication for diabetes.
He had urine incontinence due to prostate enlarge-
ment. At admission he presented mental confusion
and disorientation, axillary temperature of 38 1C
and purulent sputum. Crackles were heard in his
back, over the right inferior lung field. ChestFigure 3 Thorax CT of patient 1 confirming the new
consolidation in posterior segment of the superior right
lobe.
Figure 4 Chest radiograph of patient 2 showing patchy
consolidations in both lower lobes.radiograph presented pneumonia in the inferior
right lung (Fig. 8). White blood count was in the
normal range but band forms were 31%. His sodium
serum concentration was 132mEq/l, creatinine
1.5mg/dl, glucose 417mg/dl. He was prescribed
IV ampicillin-sulbactam 1 gr q6 h with improvement
of symptoms, being discharged after 8 days.
Sputum culture was negative and urine culture
yielded Klebsiella pneumoniae 4105/ml sensitive
to ampicillin. Chest radiograph showed no more
pulmonary lesions after 4 months (Fig. 9).Discusssion
As none of the diagnostic methods specific for
Legionella is 100% sensitive13 it is advised to use
complementary diagnostic methods to the diagno-
sis of pneumonia caused by Legionella species.14
The Legionella urinary antigen test has the best
sensitivity among the available tests.4,15 It has
been increasingly used showing patients with
positive results despite negative culture tests or
non-diagnostic serologies.15–17 Data for 1980–1998
from Center for Disease Control and Prevention
(CDC) showed that the diagnosis of Legionnaires’
disease by urinary antigen testing increased from
0% to 69%, overcoming the use of serological
testing, probably due to the fact that its sensitivity
is better than the other methods.15 Between 1995
and 1999, 167 (79%) of all legionellosis cases
notified in Australia were due to L. pneumophila
serogroup 1, 69% being detected by urinary antigen
test while only 31% by culture.16Figure 5 Chest radiograph of patient 2 after 4 days of
ampicillin-clavulanate showing that the patchy consoli-
dations increased bilaterally, mainly in the inferior right
lobe, where they progressed to an extense alveolar
pneumonia. There is also a new small patchy consolida-
tion in the right upper lobe.
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Figure 7 Thorax HRCT of patient 2 taken 60 days after
levofloxacin treatment. There is still a small consolida-
tion in the inferior left lung, which probably is the
infectious pneumonia in regression. We can see inter-
stitial lesions of collagen vascular disease: thickening of
the interlobular septa, ground-glass opacities and small
nodules.
Figure 8 Chest radiograph of patient 3 at admission
showing alveolar consolidation in the right lower lobe.
Figure 9 Chest radiograph of patient 3 showing no more
pulmonary lesions after 4 months.
Figure 6 Chest radiograph of patient 2 60 days after
levofloxacin treatment showing a significant regression of
the infectious lung lesions.
M.B.F. Chedid et al.972Most of studies on Legionella pneumonia in the
last decade used urinary antigen tests along with
other diagnostic methods.1,10,17–22 Culture remains
the
’ ’
gold standard’’ for other diagnostic methods,
but it is not widely used. A survey of hospital
laboratories in US reported that 32% were incap-
able of growing the organism, even when given a
pure culture.23 As we do not perform culture to
Legionella at our laboratory, we used serology and
urinary antigen test to estimate the incidence of
Legionnaires’ disease in our hospital.
Both World Health Organization’s (WHO)24 and
CDC case definitions for Legionnaires’ disease5
agreed that pneumonia patients who have a four-
fold or greater rise in the reciprocal immunofluor-escent antibody test titer of greater than or equal
to 1:128 against L. pneumophila serogroup 1
between paired acute- and convalescent-phase
serum specimens are confirmed cases of pneumonia
by Legionella. WHO case definition considers that a
pneumonia patient with a positive urinary antigen
test has a
’ ’
probable’’ or
’ ’
presumptive’’ disease.24
More recently, CDC case definitions for Legionnair-
es’disease5 stated that patients with pneumonia
who have positive results in urinary antigen to
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ELISA are confirmed cases of pneumonia by Legio-
nella; also stated that the previously used category
of
’ ’
probable’’ case (which was based on a single
immunofluorescent antibody titer greater than or
equal to 1:256) shall not be used because elevated
single titers of X256 against single or multiple
Legionella antigens occurred in 12% of 184 normal
control sera;25 or high prevalence of positive
antibodies at 1:256 has been reported in healthy
populations,26 so this very single titer lacks
specificity for surveillance.17 We adopted serocon-
version of X1:128 as the serological criterium of
definite infection by L. pneumophila, as well as a
positive antigen urinary test, as recommended
by CDC.
Only seven patients in our study presented
seroreactivity to L. pneumophila serogroup 1–6
(Table 2); three out of seven had only the serum
sample of acute phase to analysis, which were
seropositives at low titrations. Some authors
reported low positive titles (o1:64) in specimens
from acute phase in most of their final 74 patients
with confirmed legionellosis, while the serum
samples of convalescent phase were X1:256 in
62%.17 So, we cannot exclude Legionella etiology in
these three patients. Other two seropositives
patients in our study did not have a fourfold rise,
then patients 1 and 2 (Table 2) are the only cases of
L. pneumophila serogroup 1–6 serologically con-
firmed.
The acute-phase serum specimen of our third
patient with Legionella community-acquired pneu-
monia was missed. We got two serum samples of
convalescent phase, taken, respectively, 5 weeks
and 12 weeks after the acute episode, both being
not reagent (o1:8). In this case, the diagnosis was
made by a positive urinary antigen test only like a
noteworthy study17 in which six patients had
positive urinary antigen test and were considered
eventually as true legionellosis patients. We won-
der if our third patient would have had antibodies
in the missed acute-phase serum specimen; if not,
he might be included in the 20–30% group of
patients with Legionnaires’ disease who never
develop antibody titer elevation.27,28
In our study three patients had pneumonia
caused by L. pneumophila serogroup 1. Two
patients had both seroconversion and positive
antigen urinary test; the third patient
had a positive urinary antigen with negative
serologies. We advise every patient who has a
positive urinary test to be carefully investigated as
we did to rule out a past Legionella infection, in
order to prevent misinterpretations of the test
results.29The urine sample of patient 3 was tested along
with the urine of patient 2, after both were kept at
70 1C, respectively, for 2 and 3 months until we
made the urinary antigen test in our laboratory.
They were refrozen for 4 more months at 70 1C
and tested again at the American laboratory. The
ratio obtained there was 1.2 only, and since they
did not know Brazilian laboratory’s results, the
third urine was interpreted as negative. We believe
all our three positives urinary antigen tests are
truly positives, including the high positive ratio
obtained in our third patient (13.4). There is only
one report of false positive urinary antigen test so
far, in a patient who received rabbit sera, which
reacted with the rabbit antibodies of the EIA Binax
slides.30 We believe that this urine became nega-
tive at the American laboratory due to its storage
for more than 4 months, since a fall in the ratio of
the Legionella antigen in urines kept 3–6 months in
the freezer was already demonstrated;31 and also
22% of 18 positive urine samples stored at 70 1C
after 23–379 days became negatives when
tested by the same EIA Binax kit we used in our
patients.32
The incidence of L. pneumophila serogroups 1–6
infection in hospitalized patients with community-
acquired pneumonia in our hospital in the year
2000–2001 was 5.1%, which represents the annual
incidence of Legionnaires’ disease in a general
hospital of Southest Brazil.
Our three L. pneumophila community-acquired
pneumonia patients had common characteristics of
risk group individuals to Legionella infection:
advanced age, smoking habit, chronic pulmonary
diseases, immunosuppression.8,33,34 Patient 1 pre-
sented a progression of the radiological lesions
during specific antibiotics to Legionella despite
clinical improvement, as reported.2,28,35,36 Patient
1 and 2 worsened initially on beta-lactams, a
classical finding;2 while patient 3 improved and
got cured only on beta-lactam antibiotics, like
other recently reported patients,28,35,37 adding to
the evidences that in some cases Legionella
pneumonia may be a self-limited disease which
gets cured despite non-specific antibiotic therapy.
None of our patients with Legionella died despite
having co-morbidities, immunodepression and ad-
vanced age; and despite the fact that no one
received antibiotics to cover atypical bacteria
initially. The worsening of the disease in the first
two patients finally led to the recommended
empirical treatment. Passive surveillance data
reported that after 1990 legionellosis mortality
decreased significantly,15 probably due to the
shift in the empirical treatment of community-
acquired pneumonia ever since 1993, when it was
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Streptococcus pneumoniae and atypical bacteria.7,38
One weakness of our study is that we had to
freeze urine samples to further test it in batches
because the Legionella urinary test is not a routine
at our hospital; so we wonder if any of the urine
samples whose result was negative may have lost
the antigen while waiting in the freezer to be
tested in batches at our laboratory.
As a negative antigen urinary test in a patient
with non-diagnostic serologies does not exclude
legionellosis, other diagnostic methods should be
always done to improve the diagnostic yield. We
think we may have underestimated the incidence of
this disease in our hospital, where the culture
method is not available. The urinary antigen test
does not replace the culture to the study of
Legionella community-acquired pneumonia and
nosocomial legionellosis as well,39 rather is a very
sensitive and prompt complementary diagnostic
method to L. pneumophila infection, also being
very useful to epidemiological purposes. We be-
lieve that the urinary antigen test must be
available in the routine of every hospital to be
performed in every patient with community-ac-
quired pneumonia severe enough to require hospi-
talization, as our patients were hospitalized in the
ward and did not require ICU treatment, as well in
every patient who has risk factors of pneumonia by
Legionella.Acknowledgments
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